Essilor will unveil clinical trial results of its Stellest lens
Essilor will unveil the pivotal two–year clinical trial results of its Stellest lens – its latest spectacle lens solution in the fight against myopia. The much–anticipated two–year results demonstrate that Essilor Stellest lenses slow down myopia progression by 67% on average, when compared to single vision lenses, when worn at least 12 hours a…

